Mandeep Kaur, Ph.D.
Affiliations: | Pharmacology and Toxicology | Dartmouth College, Hanover, NH, United States |
Area:
cancer, transcription factorsGoogle:
"Mandeep Kaur"Mean distance: 17.56 (cluster 19)
Parents
Sign in to add mentor| Michael D. Cole | grad student | 2013 | Dartmouth | |
| (Understanding the mechanisms of transcriptional control by the oncoprotein MYC.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gautam N, Kaur M, Kaur S. (2020) Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: A review. Journal of Cancer Research and Therapeutics |
| Kaur M, Drake AC, Hu G, et al. (2019) Induction and Therapeutic Targeting of Human NPM1c Myeloid Leukemia in the Presence of Autologous Immune System in Mice. Journal of Immunology (Baltimore, Md. : 1950) |
| Kaur M, Hanson A, Drake A, et al. (2016) Abstract B132: A model of de novo acute myeloid leukemia with an autologous human immune system as a preclinical tool for testing immunotherapies Cancer Immunology Research. 4 |
| Kaur M, Cole MD. (2013) MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase. Cancer Research. 73: 695-705 |
| Doe MR, Ascano JM, Kaur M, et al. (2012) Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells. Cancer Research. 72: 949-57 |